Entecavir (Baraclude), an inhibitor of hepatitis B virus DNA polymerase, is the latest approved antiviral agent for chronic hepatitis B. Researchers examined the efficacy of entecavir in two ...

Entecavir is used in the treatment of HIV infection and chronic hepatitis B virus (HBV) infection. It prevents the multiplication of virus in human cells. This stops the virus from producing new ...

This leaflet answers some common questions about ENTECAVIR VIATRIS. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

Methods: Effects of entecavir were evaluated in 19 patients who had developed breakthrough hepatitis during lamivudine therapy for longer than 5 years. This study is a subgroup analysis of a ...

This drug is used with other HIV medications to help control HIV infection. Entecavir is used to treat long-term hepatitis B infection. Hepatitis B is an infection of the liver caused by the ...

Hepatitis B can develop resistance to older drugs such as lamivudine, but tenofovir and entecavir are usually effective over the long term. People with HIV co-infection should continue to use drugs ...

The trial is evaluating 248 patients with a primary endpoint of the reduction of the liver fibrosis score (Ishak Scoring System) by at least one grade after taking F351 in combination with entecavir.

patients receiving once daily doses of ALG-000184 as monotherapy or in combination with entecavir (ETV) x ≤ 64 weeks Dosing continues in this ongoing Phase 1a/1b study, with subjects planning to dose ...

Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...

Phase 3 clinical trial evaluating F351 for the treatment of CHB-associated liver fibrosis in the PRC remains on track with data anticipated by early 2025 U.S. IND submission to evaluate F351 for the ...